Novel crystalline form of enavogliflozin, and preparation method therefor
AssigneeDaewoong Pharmaceutical Co., Ltd.
InventorsYoun Jung Yoon, Hee Kyoon Yoon, Ji Soo Choi, Hye Young Ji, Hyun Woo Lim
Life of this patent
Estimating the term…
Loading patent…
AssigneeDaewoong Pharmaceutical Co., Ltd.
InventorsYoun Jung Yoon, Hee Kyoon Yoon, Ji Soo Choi, Hye Young Ji, Hyun Woo Lim
Estimating the term…
The present invention relates to a novel crystalline form of enavogliflozin, and a preparation method therefor. The novel crystalline form of enavogliflozin, according to the present invention, has thermodynamic stability and a hygroscopic property that are superior to those of a conventionally reported crystalline form of enavogliflozin, and thus has excellent long-term storage and pharmaceutical stability. In addition, the time to reach Cmax is shorter than that of the conventionally reported crystalline form of enavogliflozin such that drug effects can be rapidly exhibited, and thus the present invention can be effectively used.
A crystalline form of enavogliflozin, which is characterized by an X-ray powder diffraction pattern having four or more diffraction peaks at 2[θ] values selected from 4.93±0.2, 6.12±0.2, 7.43±0.2, 8.89±0.2, 9.74±0.2, 14.79±0.2, 15.79±0.2, 16.11±0.2, 19.79±0.2, and 22.83±0.2 in powder X-ray diffraction (PXRD) analysis.
Dependencies are inferred from the claim text.